Detalles de la búsqueda
1.
An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm patients with AML.
Blood;
141(3): 295-308, 2023 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36260765
2.
Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia.
Blood;
138(5): 387-400, 2021 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351368
3.
Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib.
Clin Breast Cancer;
19(2): e283-e296, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30737173
4.
Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study.
Cancer Chemother Pharmacol;
62(5): 911-9, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18301896
5.
Phase I and pharmacokinetic study of tasidotin hydrochloride (ILX651), a third-generation dolastatin-15 analogue, administered weekly for 3 weeks every 28 days in patients with advanced solid tumors.
Clin Cancer Res;
12(17): 5207-15, 2006 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16951240
6.
A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies.
Clin Cancer Res;
9(7): 2527-37, 2003 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12855627
7.
Challenging cases and diagnostic dilemmas: case 1. Tracheal compression in Hodgkin's disease.
J Clin Oncol;
20(15): 3344-7, 2002 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12149308
8.
Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium.
Leuk Lymphoma;
51(8): 1523-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20578815
9.
A phase I and pharmacokinetic study of the nonpolyglutamatable thymidylate synthase inhibitor ZD9331 plus docetaxel in patients with advanced solid malignancies.
Invest New Drugs;
22(4): 437-48, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15292714
Resultados
1 -
9
de 9
1
Próxima >
>>